Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC

Download PDF
Federal RegisterMar 23, 2016
81 Fed. Reg. 15567 (Mar. 23, 2016)

ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before May 23, 2016.

ADDRESSES:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:

The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

In accordance with 21 CFR 1301.33(a), this is notice that on November 12, 2015, Siegfried USA, LLC, 33 Industrial Park Road, Pennsville, New Jersey 08070 applied to be registered as a bulk manufacturer the following basic classes of controlled substances:

Controlled substance Schedule
Gamma Hydroxybutyric Acid (2010) I
Dihydromorphine (9145) I
Hydromorphinol (9301) I
Methylphenidate (1724) II
Amobarbital (2125) II
Pentobarbital (2270) II
Secobarbital (2315) II
Codeine (9050) II
Oxycodone (9143) II
Hydromorphone (9150) II
Hydrocodone (9193) II
Methadone (9250) II
Methadone intermediate (9254) II
Dextropropoxyphene, bulk (non-dosage forms) (9273) II
Morphine (9300) II
Oripavine (9330) II
Thebaine (9333) II
Opium tincture (9630) II
Oxymorphone (9652) II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Dated: March 14, 2016.

Louis J. Milione,

Deputy Assistant Administrator.

[FR Doc. 2016-06537 Filed 3-22-16; 8:45 am]

BILLING CODE 4410-09-P